Prosecution Insights
Last updated: October 04, 2026

Nyemaster Goode P.C.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

25 pending office actions • 12 clients • 23 examiners • 17 art units • 0 of 25 (0%) have an AI response strategy ready

Analysis

NYEMASTER GOODE P.C. focuses its patent practice on Biotechnology & Pharmaceuticals, managing 1143 career applications. The firm has established a resolved allowance rate of 88.88 percent.

The prosecution of these applications requires an average of 3.67 office actions per allowance. Currently, the firm is addressing 14 pending office actions. The 88.88 percent allowance rate indicates the firm's success in securing grants for its 1143 career applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1143 apps, methodology: how we score firms)

88.9%
Allowance Rate
n=1143
+0.82σ
Allowance Rate (norm)
n=1143
3.7
OAs to Allowance
n=783
-0.10σ
OAs to Allow (norm)
n=783
1011 days
Time to Allowance
n=783
+8.4pp
Interview Lift
n=1143
28.8%
RCE Rate
n=1143
1.3%
Appeal Rate
n=1143

Rejection Performance (% of received rejections ultimately overcome)

86.2%
§101 Overcome
n=65
77.1%
§102 Overcome
n=328
80.1%
§103 Overcome
n=553
81.3%
§112 Overcome
n=459

Specialization & Scale

A61K, F16L, A23L
Top CPC Subclasses
20%
Top-3 CPC Share
n=1143
3
Practitioners
n=1143
381.0
Apps / Practitioner
n=1143

Portfolio Summary

25
Total Pending OAs
15
Non-Final OAs
7
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
5
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (5)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (48%)
12
Medium (48%)
1
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (8%)
§103 only8 (32%)
§112 only1 (4%)
Double-patenting + other4 (16%)
Multi-statute (no §101)10 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
64% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
16% of docket
5
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GLIMM, CARRIE LYNN STOFFEL 3 25.6% +14.1%
ENGLISH, PETER C 1 32.8% +27.0%
ARMSTRONG, KYLE 1 71.8% +29.9%
MARTIN, PAUL C 1 41.8% +21.6%
FRONDA, CHRISTIAN L 1 82.4% +14.2%
BAKKAR, AYA ZIAD 1 63.3% +43.2%
BARRON, SEAN C 1 52.9% +30.9%
JOHNSON, DANIELLE D 1 45.0% +12.9%
SINGH, PREM C 1 59.0% +33.1%
RODRIQUEZ, KARI KRISTIN 1 55.1% +38.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18802964 Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) FRONDA, CHRISTIAN L —

Hard Cases (14)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18020010 LITHIATED SILICON LI, JUN 85d overdue
18175244 METHODS AND COMPOSITIONS FOR IMPROVING FOOD SAFETY AND ENHANCING FEED EFFICIENCY IN POULTRY GLIMM, CARRIE LYNN STOFFEL 8d
17652274 METHODS AND COMPOSITIONS FOR IMPROVING FOOD SAFETY AND ENHANCING FEED EFFICIENCY IN POULTRY GLIMM, CARRIE LYNN STOFFEL 8d
17312317 Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules WU, JULIE ZHEN QIN 12d
18230227 USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION GOTFREDSON, GAREN 27d
18741436 Brace Having Interchangeable Therapeutic Modalities RODRIQUEZ, KARI KRISTIN 28d
18195517 SELF-EMULSIFYING ANHYDROUS INTRADERMAL DEPOT GEL CHANDRAKUMAR, NIZAL S 33d
19216471 STRUCTURAL SOLAR ARCH ENGLISH, PETER C —

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18175244 METHODS AND COMPOSITIONS FOR IMPROVING FOOD SAFETY AND ENHANCING FEED EFFICIENCY IN POULTRY GLIMM, CARRIE LYNN STOFFEL 8d
17652274 METHODS AND COMPOSITIONS FOR IMPROVING FOOD SAFETY AND ENHANCING FEED EFFICIENCY IN POULTRY GLIMM, CARRIE LYNN STOFFEL 8d
18741436 Brace Having Interchangeable Therapeutic Modalities RODRIQUEZ, KARI KRISTIN 28d
19216471 STRUCTURAL SOLAR ARCH ENGLISH, PETER C —
19171575 DOCK SEGMENT COUPLING ASSEMBLY AND METHOD FOR USING ARMSTRONG, KYLE —
18902290 METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE MARTIN, PAUL C —
18802964 Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) FRONDA, CHRISTIAN L —
18800377 LIGHT BASED DENTAL TREATMENT DEVICE BAKKAR, AYA ZIAD —

Client Portfolio (12 clients)

Top Art Units

Art UnitApps
17933
37532
16122
39931
16521
37961
16531
17711
37861
16191

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19216471 STRUCTURAL SOLAR ARCH Vacuum Technologies, LLC ENGLISH, PETER C 3993 §103§112Other Non-Final OA — Pending May 22, 2025
19171575 DOCK SEGMENT COUPLING ASSEMBLY AND METHOD FOR USING Walk On Water, Inc. ARMSTRONG, KYLE §103 Non-Final OA — Pending Apr 07, 2025
18902290 METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE Kemin Industries, Inc. MARTIN, PAUL C §103 Non-Final OA — Pending Sep 30, 2024
18802964 Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) The University of Western Australia FRONDA, CHRISTIAN L 1652 §103DP Non-Final OA — Pending Aug 13, 2024
18800377 LIGHT BASED DENTAL TREATMENT DEVICE Dentosity, LLC BAKKAR, AYA ZIAD 3796 §103 Non-Final OA — Pending Aug 12, 2024
18794498 METHOD AND SYSTEM FOR TREATEMNET OF MICROORGANISMS DURING PROPAGATION, CONDITIONING, FERMENTATION, AND PRESERVATION USING LAE AND SELECTED ADDITIVES Kemin Industries, Inc. BARRON, SEAN C 1653 §103 Final Rejection — Pending Aug 05, 2024
18766645 COMPOSITIONS CONTAINING PEROXYACIDS TO CONTROL PATHOGEN GROWTH IN ANIMAL FEED AND RELATED METHODS Kemin Industries, Inc. JOHNSON, DANIELLE D §102§103§112 Non-Final OA — Pending Jul 08, 2024
18759458 HYDROCONVERSION OF A BIOMASS FEEDSTOCK TO HYDROCARBON FUELS IN A SLURRY PHASE CATALYST REACTOR Chevron U.S.A. Inc. SINGH, PREM C 1771 §103 Non-Final OA — Pending Jun 28, 2024
18741436 Brace Having Interchangeable Therapeutic Modalities Yur Brace, LLC RODRIQUEZ, KARI KRISTIN 3786 §102§103 Non-Final OA 28d Pending Jun 12, 2024
18444907 ASSEMBLY AND METHOD FOR REPAIRING PIPE HAVING MORE COMPLETE LINER EXPANSION Moray Group, LLC AHMED, FAISAL 3753 §102§103 Non-Final OA — Pending Feb 19, 2024
18444965 Light Train Centering Assembly and Method of Using Moray Group, LLC LEARY, JOSHUA DENNIS 3753 §102§103 Non-Final OA — Pending Feb 19, 2024
18422533 COPPER-ZINC ALLOY CATALYST, AND PREPARATION METHOD AND USE THEREOF Taiyuan University Of Technology JOHNSON, CHRISTINA ANN §102§112 Non-Final OA — Pending Jan 25, 2024
18230227 USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION Kemin Industries, Inc. GOTFREDSON, GAREN 1619 §101Other Non-Final OA 27d Pending Aug 04, 2023
18221987 PROCESS FOR PREPARING CANNABIS SUGAR WAX CONCENTRATE AND RELATED COMPOSITIONS AND METHODS Medpharm Iowa, LLC MOREAU, NASHARA LOUISE 1655 §103§112 Non-Final OA — Pending Jul 14, 2023
18211886 INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS Kemin Industries, Inc. ABBAS, ABDULRAHMAN MUSTAFA 1612 §103DP Non-Final OA 72d overdue Pending Jun 20, 2023
18204197 STABLE COATED CINNAMIC ALDEHYDE COMPOSITIONS FOR ANIMAL FEED AND RELATED METHODS Kemin Industries, Inc. DIVIESTI, KARLA ISOBEL 1792 §103 Non-Final OA — Pending May 31, 2023
18195517 SELF-EMULSIFYING ANHYDROUS INTRADERMAL DEPOT GEL Medpharm Holdings, LLC CHANDRAKUMAR, NIZAL S 1625 §101Other Final Rejection 33d Pending May 10, 2023
18175244 METHODS AND COMPOSITIONS FOR IMPROVING FOOD SAFETY AND ENHANCING FEED EFFICIENCY IN POULTRY Kemin Industries, Inc. GLIMM, CARRIE LYNN STOFFEL 1793 §103§112DP Final Rejection 8d Pending Feb 27, 2023
18020010 LITHIATED SILICON King'S College London LI, JUN 1732 §102§103 Final Rejection 85d overdue Pending Feb 06, 2023
18161617 METHODS AND COMPOSITIONS FOR TREATING METABOLIC CONDITIONS Kemin Industries, Inc. DICKENS, AMELIA NICOLE 1645 §112 Non-Final OA — Pending Jan 30, 2023
18084539 COMPOSITIONS CONTAINING ORGANIC ACIDS AND THEIR ESTERS TO PREVENT MOLD CONTAMINATION IN ANIMAL FEED Kemin Industries, Inc. WERTZ, ASHLEE ELIZABETH 1612 §103 Non-Final OA — Pending Dec 19, 2022
17974506 COMPOSITIONS FOR INCREASING ETHANOL PRODUCTION AND RELATED METHODS Kemin Industries, Inc. JONES-FOSTER, ERICA NICOLE 1656 §103 Final Rejection — Pending Oct 26, 2022
17856145 MICROEMULSION BASE FOR IMPROVED PIGMENT ABSORPTION AND RELATED METHODS Kemin Industries, Inc. GLIMM, CARRIE LYNN STOFFEL 1793 §102§103 Non-Final OA — Pending Jul 01, 2022
17652274 METHODS AND COMPOSITIONS FOR IMPROVING FOOD SAFETY AND ENHANCING FEED EFFICIENCY IN POULTRY Kemin Industries, Inc. GLIMM, CARRIE LYNN STOFFEL 1793 §103§112DP Final Rejection 8d Pending Feb 23, 2022
17312317 Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules The University of Western Australia WU, JULIE ZHEN QIN 1643 §102§103§112 Final Rejection 12d Pending Jun 09, 2021

Managing Nyemaster Goode P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month